ED
ESV

Exane Derivatives’s Ensco Rowan plc ESV Stock Holding History

Exane Derivatives’s Portfolio ESV Stock Details ESV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– -$9 – 769
2018
Q3 		– Hold
0
– – – 685
2018
Q2 		– Hold
0
– – – 678
2018
Q1 		– Hold
0
– – – 623
2017
Q4 		– Sell
-581
Closed -$12.9K – 606
2017
Q3 		$13.9K Sell
581
-114
-16% -$2.27K ﹤0.01% 376
2017
Q2 		$14.3K Sell
695
-220
-24% -$6.32K ﹤0.01% 378
2017
Q1 		$32.7K Buy
915
+189
+26% +$7.67K 0.01% 293
2016
Q4 		$28.2K Buy
726
+12
+2% +$430 0.01% 342
2016
Q3 		$24.3K Buy
714
+19
+3% +$646 ﹤0.01% 346
2016
Q2 		$27K Sell
695
-126
-15% -$5.23K ﹤0.01% 314
2016
Q1 		$34.1K Hold
821
– – ﹤0.01% 349
2015
Q4 		$50.6K Hold
821
– – 0.01% 260
2015
Q3 		$46.3K Buy
821
+146
+22% +$10.1K 0.01% 277
2015
Q2 		$60.1K Hold
675
– – 0.01% 273
2015
Q1 		$56.8K Buy
675
+109
+19% +$11.5K 0.01% 307
2014
Q4 		$67.8K Buy
+566
New +$81.1K 0.01% 312

Other funds holding ESV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
MAM
Majedie Asset Management London, United Kingdom $1.22B AUM 16.08% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Exane Derivatives's ESV Position: Q4 2018 in Review

Exane Derivatives held its Ensco Rowan plc (ESV) position steady in Q4 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Exane Derivatives first reported a position in ESV in Q4 2014 and has held it in 12 quarters since. The position peaked at $67.8K in Q4 2014. 324 funds tracked by Wall St. Rank hold ESV as of Q4 2018.

  • Exane Derivatives held 0 shares of Ensco Rowan plc worth $0 as of Q4 2018.
  • Exane Derivatives left its Ensco Rowan plc share count unchanged in Q4 2018.
  • Ensco Rowan plc made up ﹤0.01% of Exane Derivatives's portfolio in Q4 2018, its #769 holding.
  • Exane Derivatives first reported a position in Ensco Rowan plc in Q4 2014 and has held it in 12 quarters since.
  • Exane Derivatives's Ensco Rowan plc position peaked at $67.8K in Q4 2014.
  • 324 funds tracked by Wall St. Rank held Ensco Rowan plc as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.